Approvals/Health Canada/OLIMEL 7.6% E

Authorized

STANDARD

OLIMEL 7.6% E

baxter corporation🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 327725cbf7255a66
Company: baxter corporation
Type: Standard

Approval Details

Approval Id: 327725cbf7255a66
Drug Approval Canada Name: OLIMEL 7.6% E
Product Name: OLIMEL 7.6% E
Status: Marketed
Status Date: 2018-10-25
Original Market Date: 2018-10-25
Din: 02477955
Drug Class: Human
Dosage Form: Emulsion
Route Of Administration: Intravenous
Schedule: Ethical
Ahfs: 40:20.00
Atc Original: B05BA10 COMBINATIONS
Atc Name: b 05 ba 10
Aig Number: 2552744005
Company Name: baxter corporation
Company Address: 7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2

Active Ingredients

CALCIUM CHLORIDE

0.52 G / L

ALANINE

10.99 G / L

DEXTROSE

80.67 G / L

GLUTAMIC ACID

3.79 G / L

GLYCINE

5.26 G / L

L-THREONINE

3.79 G / L

HISTIDINE

4.53 G / L

L-ARGININE

7.44 G / L

L-LEUCINE

5.26 G / L

L-PHENYLALANINE

5.26 G / L

L-ISOLEUCINE

3.79 G / L

L-ASPARTIC ACID

2.2 G / L

L-PROLINE

4.53 G / L

L-TYROSINE

0.2 G / L

L-VALINE

4.86 G / L

MAGNESIUM CHLORIDE

0.81 G / L

METHIONINE

3.79 G / L

OLIVE OIL

28 G / L

SERINE

3 G / L

POTASSIUM CHLORIDE

2.24 G / L

SODIUM ACETATE TRIHYDRATE

1.5 G / L

SOYBEAN OIL

7 G / L

SODIUM GLYCEROPHOSPHATE

3.67 G / L

TRYPTOPHAN

1.26 G / L

LYSINE (L-LYSINE ACETATE)

5.97 G / L

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

327725cbf7255a66

Type

Standard

Back to Health Canada Approvals